We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
CVS' Health Care Delivery Arm Likely to See Better Financial Results
Read MoreHide Full Article
Key Takeaways
CVS Health's Health Care Delivery revenues rose about 25% year over year, excluding a prior business exit.
CVS recorded a $5.7B goodwill charge after reviewing and closing underperforming Oak Street clinics.
CVS targets better Health Care Delivery results via tech investments, new leadership and payer contracts.
CVS Health (CVS - Free Report) reported third-quarter 2025 results last week, wherein the performance of the Health Care Delivery business was broadly in line with the company’s expectations. Revenues rose roughly 25% year over year, excluding the impact of the exit from the CVS Accountable Care business earlier this year. The increase was mainly driven by patient growth at Oak Street and increased volumes at Signify Health.
The company has been focused on improving the business’ financial performance, particularly by addressing the market dynamics and strengthening Oak Street. The unit continued to face pressure from persistently high medical costs, member mix, and more robust benefit and supplemental benefit offerings that plans provided to their members.
During the third quarter, CVS implemented some strategic changes, including the decision to scale back the number of new Oak Street clinics planned to open over the next several years. This triggered a goodwill impairment charge of approximately $5.7 billion. Following a comprehensive review of the Oak Street clinic footprint, the company also took the decision to close underperforming clinics that lacked a reasonable path to sustainable margins.
Value-based care continues to be a critical component of CVS’ Medicare strategy. The company expects the recent actions to support improved financial performance starting next year. CVS continues to strengthen the Health Care Delivery business through investments in technology, a new leadership team, and fair and equitable contracts with its payer clients.
Updates From CVS Health Peers
UnitedHealth Group (UNH - Free Report) reported total revenues of $113.2 billion in the third quarter of 2025, up 12% year over year. This was driven by domestic membership expansion of more than 780,000 lives year to date. UNH’s adjusted earnings per share (EPS) of $2.92 were down 59.2% year over year. Meanwhile, the third-quarter medical care ratio (MCR) of 89.9% compares to 85.2% in the same quarter last year, with the full year trending toward the lower end of the projections the company offered in the previous quarter.
The Cigna Group (CI - Free Report) also posted strong results for the third quarter of 2025, with revenues up 9.5% year over year to $69.75 billion. This was mainly driven by Evernorth Health Services and includes the growth of existing client relationships and strong specialty pharmacy growth. Meanwhile, adjusted EPS of $7.83 were up 4% from the prior year’s quarter. The Cigna Healthcare MCR was 84.8% compared to 82.8% in the third quarter of 2024, driven by an updated view of risk adjustment in the individual exchange business.
CVS Stock Performance, Valuation and Estimates
Year to date, CVS Health shares have surged 74.1% compared with the industry’s 2.5% growth.
Image Source: Zacks Investment Research
CVS Health is trading at a forward five-year price/sales (P/S) ratio of 0.24, lower than the industry average of 0.46.
Image Source: Zacks Investment Research
See how the analysts are projecting CVS Health’s 2025 and 2026 earnings.
Image: Bigstock
CVS' Health Care Delivery Arm Likely to See Better Financial Results
Key Takeaways
CVS Health (CVS - Free Report) reported third-quarter 2025 results last week, wherein the performance of the Health Care Delivery business was broadly in line with the company’s expectations. Revenues rose roughly 25% year over year, excluding the impact of the exit from the CVS Accountable Care business earlier this year. The increase was mainly driven by patient growth at Oak Street and increased volumes at Signify Health.
The company has been focused on improving the business’ financial performance, particularly by addressing the market dynamics and strengthening Oak Street. The unit continued to face pressure from persistently high medical costs, member mix, and more robust benefit and supplemental benefit offerings that plans provided to their members.
During the third quarter, CVS implemented some strategic changes, including the decision to scale back the number of new Oak Street clinics planned to open over the next several years. This triggered a goodwill impairment charge of approximately $5.7 billion. Following a comprehensive review of the Oak Street clinic footprint, the company also took the decision to close underperforming clinics that lacked a reasonable path to sustainable margins.
Value-based care continues to be a critical component of CVS’ Medicare strategy. The company expects the recent actions to support improved financial performance starting next year. CVS continues to strengthen the Health Care Delivery business through investments in technology, a new leadership team, and fair and equitable contracts with its payer clients.
Updates From CVS Health Peers
UnitedHealth Group (UNH - Free Report) reported total revenues of $113.2 billion in the third quarter of 2025, up 12% year over year. This was driven by domestic membership expansion of more than 780,000 lives year to date. UNH’s adjusted earnings per share (EPS) of $2.92 were down 59.2% year over year. Meanwhile, the third-quarter medical care ratio (MCR) of 89.9% compares to 85.2% in the same quarter last year, with the full year trending toward the lower end of the projections the company offered in the previous quarter.
The Cigna Group (CI - Free Report) also posted strong results for the third quarter of 2025, with revenues up 9.5% year over year to $69.75 billion. This was mainly driven by Evernorth Health Services and includes the growth of existing client relationships and strong specialty pharmacy growth. Meanwhile, adjusted EPS of $7.83 were up 4% from the prior year’s quarter. The Cigna Healthcare MCR was 84.8% compared to 82.8% in the third quarter of 2024, driven by an updated view of risk adjustment in the individual exchange business.
CVS Stock Performance, Valuation and Estimates
Year to date, CVS Health shares have surged 74.1% compared with the industry’s 2.5% growth.
Image Source: Zacks Investment Research
CVS Health is trading at a forward five-year price/sales (P/S) ratio of 0.24, lower than the industry average of 0.46.
Image Source: Zacks Investment Research
See how the analysts are projecting CVS Health’s 2025 and 2026 earnings.
Image Source: Zacks Investment Research
CVS currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.